Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cortelazzo

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Haematologica|June 1, 1991
[Essential thrombocythemia: antiaggregants]S Cortelazzo, T Barbui
American Journal of Hematology|November 1, 1991
In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanismM Galli, S Cortelazzo, T Barbui
Thrombosis Research|July 15, 1990
Lack of cross-reactivity between anticardiolipin antibodies and glycosaminoglycansM Galli, S Cortelazzo, T Barbui
Thrombosis and Haemostasis|June 30, 1981
Platelet activation in myeloproliferative disordersS Cortelazzo, P Viero, T Barbui
Thrombosis and Haemostasis|July 29, 1984
Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?P Viero, S Cortelazzo, T Barbui
Haematologica|July 1, 1987
Hereditary dysfunctional protein C (protein C "Bergamo II") diagnosed by a rapid assayG Finazzi, P Viero, S Cortelazzo, et al.
European Journal of Cancer Care|February 13, 2010
Healthcare costs of multiple myeloma: an Italian studyD Koleva, S Cortelazzo, C Toldo, et al.
Thrombosis and Haemostasis|October 29, 1982
Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseasesP Viero, S Cortelazzo, R Bassan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 15, 2013
Does consolidation radiotherapy provide a better disease control in patients with diffuse large B-cell lymphoma of Waldeyer's ring?M Mian, A J M Ferreri, S Cortelazzo, et al.
JAMA|January 3, 1986
IgM gammopathy and the lupus anticoagulant syndrome in habitual abortersG Finazzi, S Cortelazzo, P Viero, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Haematologica|June 1, 1991
[Essential thrombocythemia: antiaggregants]S Cortelazzo, T Barbui
American Journal of Hematology|November 1, 1991
In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanismM Galli, S Cortelazzo, T Barbui
Thrombosis Research|July 15, 1990
Lack of cross-reactivity between anticardiolipin antibodies and glycosaminoglycansM Galli, S Cortelazzo, T Barbui
Thrombosis and Haemostasis|June 30, 1981
Platelet activation in myeloproliferative disordersS Cortelazzo, P Viero, T Barbui
Thrombosis and Haemostasis|July 29, 1984
Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?P Viero, S Cortelazzo, T Barbui
Haematologica|July 1, 1987
Hereditary dysfunctional protein C (protein C "Bergamo II") diagnosed by a rapid assayG Finazzi, P Viero, S Cortelazzo, et al.
European Journal of Cancer Care|February 13, 2010
Healthcare costs of multiple myeloma: an Italian studyD Koleva, S Cortelazzo, C Toldo, et al.
Thrombosis and Haemostasis|October 29, 1982
Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseasesP Viero, S Cortelazzo, R Bassan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 15, 2013
Does consolidation radiotherapy provide a better disease control in patients with diffuse large B-cell lymphoma of Waldeyer's ring?M Mian, A J M Ferreri, S Cortelazzo, et al.
JAMA|January 3, 1986
IgM gammopathy and the lupus anticoagulant syndrome in habitual abortersG Finazzi, S Cortelazzo, P Viero, et al.
Pageof 9